1. Preconditioning the human myocardium: Recent advances and aspirations for the development of a new means of cardioprotection in clinical practice

   • David P. Jenkins
   • Stephen E. Steare
   • Derek M. Yellon

   Reviews Pages: 739 - 747

2. Additional antiischemic effects of long-term L-propionylcarnitine in anginal patients treated with conventional antianginal therapy

   • G. Louis Bartels
   • Willem J. Remme
   • Dick A. C. M. Kruijssen

   Angina Pectoris Pages: 749 - 753

3. Effect of nicorandil on abnormal coronary flow reserve assessed by exercise²⁰¹Tl scintigraphy in patients with angina pectoris and nearly normal coronary arteriograms

   • Hiroshi Yamabe
   • Hiroyuki Namura
   • Mitsuhiro Yokoyama

   Angina Pectoris Pages: 755 - 761

4. Randomized, controlled trial of antioxidant vitamins and cardioprotective diet on hyperlipidemia, oxidative stress, and development of experimental atherosclerosis: The diet and antioxidant trial on atherosclerosis (DATA)

   • Ram B. Singh
   • Arif M. Niaz
   • Fred A. Kummerow

   Atherosclerosis Pages: 763 - 771

5. Iloprost antagonizes the increase in internal calcium concentration induced by α-thrombin in human platelets: A study of desensitization

   • Enrica Cecchi
   • Laura Capone
   • Paola Failli

   Platelet Function Pages: 773 - 777

6. “Essential” phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart disease

   • Anatoli N. Klimov
   • Vladimir O. Konstantinov
   • Rainer Schumacher

   Lipids Pages: 779 - 784

7. Behavior of Lp(a) and apoproteins (A1, B, C2, C3, E) during and after therapy with simvastatin

   • T. Sampietro
   • F. Galetta
   • A. Bionda

   Lipids Pages: 785 - 789

8. Intravenous dopexamine in the treatment of acute congestive heart failure: Results of a multicenter, double-blind, placebo-controlled withdrawal study

   • Hidetsugu Asanoi
   • Shigetake Sasayama
   • the Investigators of the Dopexamine Multicenter Study

   Congestive Heart Failure Pages: 791 - 797

9. 24 hour blood pressure control with once-daily versus twice-daily formulations of diltiazem

   • Terrence D. Ruddy
   • James M. Wright
   • The Canadian Multicenter Diltiazem CD Hypertension Trial Group

   Hypertension Pages: 799 - 807

10. Semotiadil inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension

    • Takashi Takahashi
    • Tsugiyasu Kanda
    • Kazuhiko Murata

    Experimental Pharmacology Pages: 809 - 814

11. Blockade of receptor-operated calcium channels by mibefradil (Ro 40-5967): Effects on intracellular calcium and platelet aggregation

    • Martina Hahn
    • Vsevolod A. Tkachuk
    • Jean-Paul Clozel

    Experimental Pharmacology Pages: 815 - 821

12. Effects of Na⁺-H⁺ exchange blocker amiloride on left ventricular remodeling after anterior myocardial infarction in rats

    • Shuuichi Hasegawa
    • Masayuki Nakano
    • Tadashi Suzuki

    Experimental Pharmacology Pages: 823 - 826

13. Sudden hypothyroidism and amiodarone-lithium combination: An interaction

    • Saeed Ahmad

    Experimental Pharmacology Pages: 827 - 828

14. Increase of plasma digoxin levels after withdrawal from therapy in an elderly patient

    • Zijad Duraković

    Letter To The Editor Pages: 829 - 830

15. Does plasma endothelin during thrombolysis depend on infarct size? A pilot study

    • Pietro Di Pasquale
    • Salvatore Paterna
    • Giuseppe Licata

    Letter To The Editor Pages: 831 - 832

16. Book review

    • G. F. Baxter
    • Lionel H. Opie

    BookReview Pages: 833 - 835

17. Referee awards

    Acknowledgments Pages: 837 - 837

18. In appreciation

    Acknowledgments Pages: 839 - 839

19. Announcement of the International Albrecht Fleckenstein Award in 1996

    Announcement Pages: 871 - 871